Literature DB >> 28741718

Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology.

Elie Nader1,2, Philippe Connes1,2,3, Yann Lamarre2,4, Céline Renoux1,2,5, Philippe Joly1,2,5, Marie-Dominique Hardy-Dessources2,4, Giovanna Cannas1,6,7, Nathalie Lemonne8, Samir K Ballas9.   

Abstract

Mesh：

Year:  2017        PMID： 28741718     DOI： 10.1002/ajh.24870

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

1.  Successful treatment of acute sickle cell intrahepatic cholestasis with therapeutic plasma exchange.

Authors:  Dimitris A Tsitsikas; Rhys Hall; John Meenan; Funmilayo Orebayo; Oloruntoyin Bello-Sanyaolu; Saket Badle; Manisha Sharma; Susan Jain; Jun Liong Chin
Journal:  EJHaem       Date:  2021-01-06

2.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 3.  Blood Rheology: Key Parameters, Impact on Blood Flow, Role in Sickle Cell Disease and Effects of Exercise.

Authors:  Elie Nader; Sarah Skinner; Marc Romana; Romain Fort; Nathalie Lemonne; Nicolas Guillot; Alexandra Gauthier; Sophie Antoine-Jonville; Céline Renoux; Marie-Dominique Hardy-Dessources; Emeric Stauffer; Philippe Joly; Yves Bertrand; Philippe Connes
Journal:  Front Physiol       Date:  2019-10-17       Impact factor: 4.566

4.  Fat Embolism Syndrome in Sickle Cell Disease.

Authors:  Dimitris A Tsitsikas; Jessica Vize; Jibril Abukar
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.